Insulin Delivery Devices Market growth outlook with industry review and forecasts

1
Insulin Delivery Devices Market share research by
applications and regions for 2017-2024 Global
Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Regional Analysis of Insulin Delivery Devices
Market

• U.S. insulin delivery devices market accounted
  for largest market share in 2016 owing to
  increasing awareness levels amongst the affected
  population. Increasing diabetic population and
  the availability of technologically advanced
  devices are the factors leading to the high
  market growth. Also, as per Canadian Diabetes
  Association, the prevalence of diabetes is
  increasing in Canada and it is projected to reach
  over 4 million by 2025. Forming a large patient
  base with diabetes and its growing incidence is
  likely to enhance the growth in the U.S. region
  for insulin delivery devices market during the
  forecast period.
• India and China, are anticipated to witness
  significant growth during the forecast period due
  to the existence of a vast patient base suffering
  with diabetes and rising awareness of insulin
  delivery devices. In addition, large number of
  regional players are expanding their business by
  providing high-end products for diabetes care.

3

• Application Analysis of Insulin Delivery Devices
  Market
• Insulin pens accounted for highest market share
  in 2016, owing to its benefits such as its
  user-friendly design, high adoption rate, and
  increasing acceptance amongst consumers. Rising
  focus of companies on product innovation should
  yield the high industry share. For example, Novo
  Nordisk launched a new device called NovoPen Echo
  in the U.S. It was the first device of its kind,
  with a half-unit dosage feature and memory
  function.
• Homecare segment will continue to account for
  maximum market share during the forecast period.
  The significant factors resulting in substantial
  growth are growing adoption of insulin delivery
  devices and increasing awareness of diabetes
  care. Home usage of insulin devices saves
  additional visiting costs, clinic, or hospital
  fee, and waiting time. The developed devices
  including pens, pumps, and injectors, are small,
  highly portable, and give a comfort of using them
  anywhere and anytime. Therefore, better access to
  such delivery devices and their developed ease of
  usage has enabled insulin users opt for self-care
  diabetes management options.

4
Competitive Market Share of Insulin Delivery
Devices Market

• Companies operating in insulin delivery devices
  market include Novo Nordisk (Subsidiary of Novo
  A/S), Tandem Diabetes Care, Sanofi, Medtronic,
  Valeritas, Becton, Dickinson and Company, Eli
  Lilly, F. Hoffmann-La Roche, Ypsomed, Owen
  Mumford, Animas, Insulet Corporation, Asante
  Solutions (Now Bigfoot Biomedical), Abbott
  Laboratories, Biocon Ltd., Antares Pharma,
  Bioject Medical Technologies, Injex - Equidyne
  Systems, Tonghua Dongbao Pharmaceutical, Shanghai
  Fosun Pharmaceutical.

5

Browse Full Market Research Report On Insulin
Delivery Devices Market _at_ https//goo.gl/jn5ysG R
equest for an in-depth table of contents for this
report _at_ https//www.gminsights.com/request-toc/up
coming/1649 Gaming Console Market
6
Stay In Touch Website www.gminsights.com Soci
al Media